Fluoxetine is used in the treatment of a variety of clinical disorders including depression and obesity, and of cocaine detoxification or alcoholism. It is generally believed that fluoxetine exerts its clinical effects because it selectively blocks 5-hydroxytryptamine (5HT) reuptake into nerve terminals. In here we describe that fluoxetine antagonized the neuronal homomeric ␣ 7 nicotinic acetylcholine receptors (nAChR) expressed in Xenopus oocytes, with an IC 50 of 43 M, when fluoxetine was coapplied with ACh, and of 1.6 M when the oocytes were pretreated briefly with fluoxetine. A similar block occurred in oocytes expressing L247T ␣ 7 mutant nAChR. Furthermore, blockage of mutant ␣ 7 receptors appeared non-competitive and was stronger with cell membrane hyperpolarization. Cell-attached single channel recordings in oocytes expressing L247T ␣ 7 mutant nAChR showed that the voltage-dependence of the blockage by fluoxetine could be due to a drastic decrease in channel opening frequency accompanied by marked channel flickering and reduced channel conductance. We conclude that fluoxetine behaves as a reversible blocker of both wild and mutant ␣ 7 receptors; and that the Leu-247T mutation in the channel domain renders the blockage of ␣ 7 nAChR by fluoxetine voltagedependent. These effects of fluoxetine on ␣ 7 receptors may be clinically important.A great deal of interest has recently focused on the neuronal nicotinic ␣ 7 receptor due to its special structural and functional characteristics as compared to other members of the nicotinic receptor family. In particular, the ␣ 7 subunit forms functional homomeric receptors; 1,2 and the substitution of the conserved leucine 247 for threonine, in the M2 channel domain, changes drastically their function. [3][4][5] Fluoxetine is a potent inhibitor of 5HT uptake that is used extensively in clinical practice; and it was thought that its therapeutic effects were essentially due to blocking of the 5HT-transporter. 6 However, we have recently shown that fluoxetine is a potent blocker of nicotinic receptors, inhibiting not only heteromeric muscular but also neuronal nicotinic receptors expressed in Xenopus oocytes. 7 The experiments reported here were done in oocytes injected with ␣ 7 subunit cDNA to investigate whether fluoxetine would also block homomeric ␣ 7 nAChR. Fluoxetine was also used as a tool to investigate further the role of the Leu-247 residue as a determinant of the functional and pharmacological profiles of the ␣ 7 receptor.Oocytes injected with the wild-type ␣ 7 subunit cDNA had a membrane potential of −38 ± 4 mV and responded to ACh with an inward current (I ACh ) whose peak amplitude depended on transmitter concentration. In oocytes held at −60 mV, 150 M ACh, a concentration close to the EC 50 for ␣ 7 nAChR, 1,8-10 elicited a mean acetylcholine-current (I ACh ) of −77 ± 13 nA (mean ± sem n = 15; two donors, range −20 nA to −177 nA), that decayed to 90% (T 0.1 ) in 0.81 ± 0.01 s. Fluoxetine alone (100 M) did not elicit obvious current responses in either non-inject...